COMMUNIQUÉS West-GlobeNewswire

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix
31/07/2024
Limited market release marks first xenograft addition to Company’s portfolio of leading Wound and Surgical products MARIETTA, Ga., July 31, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “ [...]
Standard BioTools Announces Senior Leadership Changes
31/07/2024
Alex Kim, Chief Operating Officer and Standard BioTools Co-Founder, to Serve as interim Chief Financial Officer Following Departure of Jeffrey Black on August 31, 2024 Industry Veteran Sean Mackay Named Chief Business [...]
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
31/07/2024
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 44 th [...]
MIMEDX Announces Second Quarter 2024 Operating and Financial Results
31/07/2024
Net Sales of $87 Million Grew 7% Year-Over-Year for the Second Quarter Second Quarter GAAP Net Income and Earnings Per Share were $18 Million and $0.12 , Respectively Second Quarter Adjusted EBITDA was $20 Million, or [...]
ALX Oncology Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer
31/07/2024
Evorpacept is the first CD47 blocker to show durable clinical benefit and a well-tolerated safety profile in a prospective randomized trial Evorpacept combination achieved a confirmed overall response rate (ORR) of 40.3 [...]
PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time
31/07/2024
PRINCETON, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets [...]
Standard BioTools Reports Second Quarter 2024 Financial Results
31/07/2024
Delivered revenue of $37.2 million Accelerated merger synergies with $80 million expected to be operationalized in 2024 Revised FY2024 revenue guidance; on-track to achieve anticipated break-even adjusted EBITDA for [...]
Inventiva Reports Preliminary 2024 First-Half Financial Information¹
31/07/2024
Cash and cash equivalents at €10.1 million as of June 30, 2024, compared to cash and cash equivalents at €26.9 million, €0.01 2 million of short-term deposits and €9.0 3 million of long-term deposits as of December 31, [...]
Inventiva publie ses informations financières préliminaires du premier semestre 2024¹
31/07/2024
Trésorerie et équivalents de trésorerie à 10,1 millions d’euros au 30 juin 2024, contre 26,9 millions d’euros, 0,01 2 million d’euros de dépôts à court terme et 9,0 3 millions d’euros de dépôts à long terme au 31 [...]
GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR
31/07/2024
Rutherford, NJ, July 31, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel [...]
HilleVax Announces Reduction in Force
31/07/2024
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a workforce reduction to [...]
Eurobio Scientific: CONCLUSION D’UN ACCORD ENTRE EUROBIO SCIENTIFIC ET UN CONSORTIUM MENÉ PAR L’ÉQUIPE D’ENTREPRENEURS ET DIRIGEANTS D’EUROBIO SCIENTIFIC, IK PARTNERS ET NEXTSTAGE AM EN VUE DU DÉPÔT D’UNE OFFRE PUBLIQUE D’ACHAT VOLONTAIRE A
31/07/2024
NE PAS DISTRIBUER, PUBLIER OU DIFFUSER, EN TOUT OU EN PARTIE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS OU A TOUTE PERSONNE DES ETATS-UNIS, OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE LA DISTRIBUTION, LA [...]
EUROBIO SCIENTIFIC: CONCLUSION OF AN AGREEMENT BETWEEN EUROBIO SCIENTIFIC AND A CONSORTIUM LED BY EUROBIO SCIENTIFIC'S TEAM OF ENTREPRENEURS AND MANAGERS, IK PARTNERS AND NEXTSTAGE AM WITH A VIEW TO FILE A VOLUNTARY TENDER OFFER AT A PRICE
31/07/2024
NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO ANY US PERSON, OR TO ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD [...]
Eurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENT // PROPOSED TENDER OFFER
31/07/2024
NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO ANY US PERSON, OR TO ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD [...]
Eurobio Scientific : PREMIER SEMESTRE 2024, UN SOLIDE DEBUT D’EXERCICE DANS UN CONTEXTE INCERTAIN // PROJET D’OFFRE PUBLIQUE
31/07/2024
NE PAS DISTRIBUER, PUBLIER OU DIFFUSER, EN TOUT OU EN PARTIE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS OU A TOUTE PERSONNE DES ETATS-UNIS, OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE LA DISTRIBUTION, LA [...]
ARCPOINT ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT AND WARRANT AMENDMENTS
31/07/2024
Not for Dissemination in the United States or through U.S. Newswire Services Greenville, South Carolina, July 31, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to [...]
NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call
31/07/2024
WOBURN, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2024 second quarter business and financial highlights before the opening of the market on [...]
AMN Healthcare Launches Executive Advisory Board
31/07/2024
Move brings experienced, accomplished health leader to help AMN address healthcare industry’s workforce challenges DALLAS, July 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN) is taking steps to further [...]
Betterguards Unveils New Sports Tech, The BetterGuard 2.0
31/07/2024
Intelligent ankle brace technology offers preventative support against common ankle injuries NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- Betterguards , a next-generation sports technology innovator, announces the launch [...]

Pages